Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 8:13 pm Purchase | 2024-11-20 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 432,276 6.760% | 432,276 (New Position) | Filing History |
| 2024-12-06 4:05 pm Purchase | 2024-11-30 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 958,925 15.000% | 876,227 (+1059.55%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 151,433 9.990% | 151,433 (New Position) | Filing History |
| 2024-11-14 4:02 pm Purchase | 2024-09-30 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 82,698 5.700% | 82,698 (New Position) | Filing History |
| 2024-06-17 06:24 am Sale | 2024-06-14 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,480 4.000% | -4,607 (-7.30%) | Filing History |
| 2024-02-14 4:56 pm Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 145,345 9.900% | 234 (+0.16%) | Filing History |
| 2024-02-14 4:54 pm Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 145,219 9.990% | 145,219 (New Position) | Filing History |
| 2024-02-14 4:11 pm Unchanged | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 73,559 5.100% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:33 am Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners L.P. | 151,740 9.900% | 234 (+0.15%) | Filing History |
| 2024-01-10 5:39 pm Purchase | 2024-01-10 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 70,468 4.800% | 1,065 (+1.53%) | Filing History |
| 2024-01-08 6:17 pm Unchanged | 2023-07-06 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 81,279 5.590% | 0 (Unchanged) | Filing History |
| 2024-01-05 5:27 pm Unchanged | 2024-01-03 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 63,087 4.300% | 0 (Unchanged) | Filing History |
| 2023-09-15 12:00 pm Unchanged | 2023-09-15 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 69,403 4.780% | 0 (Unchanged) | Filing History |
| 2023-09-11 8:54 pm Purchase | 2023-08-31 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 73,559 5.100% | 73,559 (New Position) | Filing History |
| 2023-09-08 12:47 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 145,111 9.900% | 117,111 (+418.25%) | Filing History |
| 2023-08-23 4:47 pm Purchase | 2023-08-16 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 63,087 4.300% | 10,416 (+19.77%) | Filing History |
| 2023-08-15 5:15 pm Purchase | 2023-07-31 | 13D | Forte Biosciences, Inc. FBRX | Wagner Paul A. | 76,048 5.210% | 24,886 (+48.64%) | Filing History |
| 2023-08-10 4:34 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | BIOTECHNOLOGY VALUE FUND L P | 119,284 8.200% | 119,284 (New Position) | Filing History |
| 2023-08-10 3:57 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners L.P. | 151,505 9.900% | 151,505 (New Position) | Filing History |
| 2023-08-10 09:20 am Unchanged | 2023-08-18 | 13D | Forte Biosciences, Inc. FBRX | ATG Fund II LLC | 58,480 4.000% | 0 (Unchanged) | Filing History |